HCA Healthcare Inc. (HCA) is owned by a number of high-value investors. Its largest direct holder is Robert A. Waterman Senior Vice President and General Counsel with 262,655 shares. The second-largest direct holder is A. Bruce Moore President, Service Line and Operations Integration, with 224,585 shares of the company’s stock. In third place with 194,145 shares of HCA is Victor L. Campbell Senior Vice President – Government Affairs.
Now turning to institutional ownership of HCA Healthcare Inc. (HCA), The Vanguard Group, Inc. is the top holder with 20.54 million shares. The next largest fund holder of this company’s stock is T. Rowe Price Associates, Inc. (Investment Management) with 17.55 million shares. In the third-place spot with 15.81 million shares is Magellan Asset Management Ltd..
This company’s stock price was $138.17 at the previous market close, with its latest volume reaching 1407225. Compare that to its average daily volume of 1.47M. Given the fact that this stock has 342.28M shares outstanding, its current market value is sitting at $47.29B. This publicly-traded stock’s 60-month Beta is 0.91. Its Price to Sales ratio is 0.94, its Price to Cash Flow ratio is 84.60.
HCA stock has achieved a 5-day range of $136.40 to $141.28, with a total performance of -0.53% during that period. Meanwhile, in the past month of trading, this stock has traded in the range of $133.10 to $141.89, generating a +3.38% change during the period. In the past three months, this stock’s price has changed by +15.18%, trading in the range of $114.13 to $141.89.
In the past 5 days, shares of HCA have made a new high 1 time. In the last month, it has made a new high 6 times, and in the past 3 months, it has made a new high 15 times.
Now let’s turn to this public company’s earnings. For the quarter ending 9/29/2019, the earnings per share (EPS) was reported at 2.23. This is a 0.1 difference compared to the consensus estimate of 2.13, amounting to an earnings surprise of 4.70%. In the previous quarter, which ended in 9/29/2019, the consensus estimate was 2.46, making for an earnings surprise of -10.20%. For the quarter ending 3/30/2019, EPS was reported at 2.97, generating a 28.00% earnings surprise.
The Net Income for the most recent full fiscal year, which ended in 12-2018, was $4.39 billion. This is compared to the prior year, where Net Income was $2.74 billion. Meanwhile, this company’s Operating Cash Flow was $6.76 billion for the year, compared to $5.43 billion in 2017. Capital Expenditures for the year were reportedly -$3.57 billion, compared to -$3.02 billion, and Free Cash flow was $3.19 billion compared to the prior year’s $2.41 billion.
HCA Healthcare Inc. (HCA) stock currently has a Financial Strength score of 3/10. This is due to a combination of factors, including a Cash to Debt ratio of 0.02, an Equity to Asset ratio of -0.08, a Debt to Equity ratio of -10.01 and a Debt to EBITDA of 3.78. The Interest Coverage of this stock is 3.88, its Piotroski F-Score is 8, its Altman Z-Score is 2.29.
This publicly-traded company’s Profitability and Growth score is 9/10, thanks to a combination of things: an Operating Margin of 14.21, a Net Margin of 6.98 and a ROC of 27.67.
Shifting focus now to Valuation and Return for HCA, this company’s Price to Median PS Value is 1.29. Price to Peter Lynch Fair Value for HCA is now 1.07. Meanwhile, its Forward Rate of Return (Yactman) is 18.1.
Certain ratios provide helpful insights into how a stock is performing. The Quick Ratio for HCA is sitting at 1.26, while its Current Ratio is 1.51 and its PEG Ratio is 1.05. This stock’s PS Ratio is 0.97, its Forward PE Ratio is 12.11, and its PE Ratio without NRI is 13.83. Similarly, its Shiller PE Ratio is 23.48, its Price to Owner Earnings is 14.83, its Price to Free Cash Flow is 14.92 and its Price to Operating Cash Flow is 6.65.